Research investigating how arsenic contamination in soil and water reduces antioxidant nutrients (iron, selenium, vitamin C, carotenoids, polyphenols) in vegetables, with significant implications for food quality and nutrition of vulnerable populations in Argentina.
This research addresses a critical food safety and nutrition concern: how arsenic contamination in agricultural environments affects the nutritional quality of crops. The study investigates the relationship between arsenic exposure and the reduction of key antioxidant nutrients in vegetables, with particular attention to implications for vulnerable populations such as children who have higher nutritional requirements. By examining vegetables grown in two areas of Argentina with differing arsenic levels in soil and water, this work aims to quantify how environmental contamination translates into diminished nutritional value in the food supply.
Study design:
Variables measured:
Analytical methods:
Current resource needs:
This is an early-stage research initiative in the planning and resource acquisition phase. The research hypothesis is established based on documented evidence that plants absorb arsenic through multiple mechanisms, leading to growth inhibition, chlorophyll degradation, nutrient loss, and oxidative stress. The study design is defined, but validation work has not yet commenced pending acquisition of necessary analytical standards and laboratory supplies. Once funded, the cross-sectional study will generate baseline data on the relationship between arsenic contamination and antioxidant nutrient depletion in crops, providing foundational evidence for food quality assessment and potential mitigation strategies.
Universidad de Buenos Aires (UBA) is a comprehensive public research university and one of Latin America’s largest, with a broad academic footprint and high research intensity. Industry partners engage through campus-embedded laboratories, testing and analysis services, and a dedicated technology transfer entity that brokers contracts, IP licensing, and spinouts. Clinical integration with UBA‑affiliated hospitals and clinics enables access to diverse patient populations and pathways for translational studies, while its citywide footprint places teams near major corporate operations. Research is supported by competitive funding from national science and innovation agencies and international programs. A central corporate engagement function streamlines NDAs, MTAs, and sponsored research agreements to shorten time‑to‑collaboration.